ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
97,979.48
-0.33%
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs Yen
157.64
0.08%
Brent Oil
76.615
0.14%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Cullinan Therapeutics Inc (CGEM) 銘柄情報

Cullinan Therapeutics Inc

Cullinan Therapeutics Inc (CGEM)

NASDAQ
12.68
0.29
(2.34%)
終了 1月6日 6:00AM
15分遅延
12.68
-0.019
(-0.15%)
取引時間後: 6:04AM
15分遅延

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
12.68
買値
12.50
売値
13.55
出来高
294,046
12.45 日の範囲 12.985
9.95 52 週間の範囲 30.1886
時価総額
738.326M
前日終値
12.39
始値
12.45
時刻
1
@
12.68
最終取引時間
財務取引量
US$ 3,739,464
VWAP
12.7173
平均取引量 (3 か月)
526,586
発行済株式数
58,227,593
配当利回り
-
PER
-4.83
1 株当たり利益 (EPS)
-2.63
歳入
-
純利益
-153.16M

Cullinan Therapeutics Inc について

Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
www.cullinantherapeutics.com
本社
Wilmington, Delaware, USA
設立
-
Cullinan Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker CGEM. The last closing price for Cullinan Therapeutics was US$12.39. Over the last year, Cullinan Therapeutics shares have traded in a share price range of US$ 9.95 to US$ 30.1886.

Cullinan Therapeutics currently has 58,227,593 shares in issue. The market capitalisation of Cullinan Therapeutics is US$721.44 million. Cullinan Therapeutics has a price to earnings ratio (PE ratio) of -4.83.

CGEM 最新ニュース

その他のニュース

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月21日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月21日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月21日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月17日
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2024年11月15日
Edgar (US Regulatory)

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global...

2024年11月15日
GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

2024年11月9日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年11月8日
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2024年11月7日
Edgar (US Regulatory)

Form 8-K - Current report

2024年11月7日
Edgar (US Regulatory)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.2-1.5527950310612.8812.9511.7580938412.11692463CS
40.161.2779552715712.5213.610.4454503911.99233032CS
12-3.21-20.201384518615.8917.97510.4452658613.88794604CS
26-3.78-22.96476306216.4621.0110.4458692316.18424043CS
522.0919.735599622310.5930.18869.9563420418.21256416CS
156-3.02-19.235668789815.730.18867.337842515.11624258CS
260-29.32-69.80952380954259.857.335071317.82503229CS

CGEM - Frequently Asked Questions (FAQ)

What is the current Cullinan Therapeutics share price?
The current share price of Cullinan Therapeutics is US$ 12.68
How many Cullinan Therapeutics shares are in issue?
Cullinan Therapeutics has 58,227,593 shares in issue
What is the market cap of Cullinan Therapeutics?
The market capitalisation of Cullinan Therapeutics is USD 721.44M
What is the 1 year trading range for Cullinan Therapeutics share price?
Cullinan Therapeutics has traded in the range of US$ 9.95 to US$ 30.1886 during the past year
What is the PE ratio of Cullinan Therapeutics?
The price to earnings ratio of Cullinan Therapeutics is -4.83
What is the reporting currency for Cullinan Therapeutics?
Cullinan Therapeutics reports financial results in USD
What is the latest annual profit for Cullinan Therapeutics?
The latest annual profit of Cullinan Therapeutics is USD -153.16M
What is the registered address of Cullinan Therapeutics?
The registered address for Cullinan Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Cullinan Therapeutics website address?
The website address for Cullinan Therapeutics is www.cullinantherapeutics.com
Which industry sector does Cullinan Therapeutics operate in?
Cullinan Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
CRNCCerence Inc
US$ 19.33
(143.76%)
159.55M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.78M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
230.01M

CGEM Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
CGEM
Cullinan Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有